The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Convicted fraudster and inmate Jermaine Prim is due back in the Palm Ridge Commercial Crimes Court on Monday for sentencing. Prim drew widespread attention over the weekend after a television ...

The correctional services department (DCS) has launched a full-scale investigation into a telephonic interview conducted by news channel eNCA with inmate Jermaine Prim at the Johannesburg Correctional ...

Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

We combine academic excellence with hands-on learning in a breathtaking alpine setting. From sustainability studies and semester-long immersions, to weekend courses and career-focused programs, every ...

JOHANNESBURG - Convicted fraudster Jermaine Prim, who has been in prison for over eight years, will be sentenced on Monday. Prim alleges that Patriotic Alliance leader Gayton McKenzie and some of his ...

Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) decreased during the last reporting period, falling from 174.14M to 173.93M. This put 35.4% of the company's publicly available shares ...